Page results
-
This patient information offers advice for patients suffering from long COVID regarding a healthy diet and nutrition.
-
This page is for patients who are receiving radiotherapy to the bladder. It explains what the treatment involves, describes side-effects you may experience during and after treatment, and how best to cope with them.
-
UCLH provides a comprehensive service to diagnose, treat and support people with cancer. We are a specialist centre for many types of cancer and treat patients from both our local area and across the country.
-
This booklet explains what you can expect during recovery from your autologous stem cell transplant.
-
Complex travel appointments are available through NHS referral or private pay. Please note that an NHS referral is only valid in certain cases.
-
We provide a wide range of general paediatric services, led by a team of enthusiastic consultants and dedicated nurses.
-
Patient information for patients undergoing Image Rehearsal Therapy (IRT).
-
This is information for women about medical management after an ultrasound diagnosis of a miscarriage.
-
This page aims to help you, your family and carers to plan ahead and talk about decisions about your care and treatment that may need to be made in the future.
-
Information about the musculoskeletal medicine service at the Royal London Hospital for Integrated Medicine.
File results
-
FOI/2023/0007 - Outpatient activity for 2022
-
FOI/2023/0009 - Procedure volumes/ average costs for portable and stable oxygen concentrator devices
-
FOI/2023/0010 - Bardet-biedle Syndrome patient treatment and diagnosis
-
FOI/2023/0013 - Average waiting times for colonoscopy investigations
-
FOI/2023/0014 - Surgery protocols/ standard operating procedures for a feticide
-
FOI/2023/0018 - A&E attendances/ admissions by patients of no fixed abode
-
FOI/2023/0019 - Public access to water refill stations on your premises
-
FOI/2023/0022 - Guidelines staff follow for patients with disabilities and autism
-
FOI/2023/0226 - Treatment with Nivolumab
-
FOI/2023/0225 - Usage of Dabrafenib + Trametinib in cancer treatment